ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Mar 31, 2021 14:09 JST
Source:
Toyota Motor Corporation
Toyota: First Refrigerated Vehicle for Vaccine in the World to Obtain WHO's Performance, Quality and Safety Prequalification
Establishing methods for refrigerated vaccine transportation and contributing toward improving the rate of vaccine use in developing countries
Toyota City, Japan, Mar 31, 2021 - (JCN Newswire) - Toyota Tsusho Corporation, Toyota Motor Corporation, and B Medical Systems S.a r.l. announced today that the vehicle with a dedicated refrigerator for transporting vaccines at the appropriate temperatures developed jointly by the three companies has obtained Performance, Quality and Safety (PQS) prequalification for quality of medical devices and equipment as set by the World Health Organization (WHO). The company registered for the prequalification is Toyota Tsusho and this is the first refrigerated vehicle for vaccines in the world that has obtained PQS prequalification.
1. Background
Vaccination is an effective measure against infectious diseases. General mandatory vaccines for infants usually require storage at 2 to 8degC, and cannot be used if not stored under proper temperature management. Although developing countries receive assistance from international agencies such as GAVI, the Vaccine Alliance and UNICEF for the supply of vaccines, approximately 20% of the volume supplied (equivalent to JPY 40 billion per year) are disposed annually because they become unusable due to temperature changes during transportation when distributing to hospitals and clinics within the respective countries, as the road infrastructures are inadequate and there is no proper means for refrigerated transportation. Each year, the lives of 1.5 million children are lost to vaccine preventable diseases (VPD) with insufficient effective utilization of vaccines being one of the reasons.
2. WHO's PQS and Significance of Prequalification
PQS is a system for the qualification of medical devices and equipment by WHO that was established to promote the development of medical devices and equipment applicable for the United Nations' procurement as well as to set quality standards. Medical devices and equipment which have obtained PQS prequalification also meet the equipment selection standards of agencies related to the United Nations and leading NGOs and charity organizations.
Also, it is easier for developing countries without their own qualification system for medical devices and equipment to receive support for transportation equipment procurement by using PQS as the qualification standard, and effective use of vaccines can be expected.
This initiative contributes to the effective use of vaccines, addressing a social issue in developing countries. At the same time, it has the significance of being able to demonstrate initiative in the field of global health transportation. In addition, this refrigerated vehicle for vaccines can now be used under the international framework COVAX, which seeks to distribute vaccines for COVID-19 fairly to developing countries, and its use as a means of transportation for COVID-19 vaccines can also be expected.
3. Overview of Refrigerated Vehicle for Vaccines
The features of the refrigerated vehicle for vaccines which obtained PQS prequalification this time are as follows:
- The base vehicle is Toyota Land Cruiser 78, which is equipped with the B Medical Systems' CF850 vaccine refrigerator.
- The refrigerator has a storage capacity of 396 liters, or 400 vaccine packages.
- With its independent battery, the refrigerator can be operated for approximately 16 hours without a power supply.
- The refrigerator can be charged by the vehicle while driving and from an external power source when parked.
4. Roles of Each Company
1. Toyota Tsusho uses the knowledge and awareness of issues developed through business in Africa to provide the refrigerated vehicle for vaccines as the company obtaining PQS prequalification.
2. Toyota provides the Toyota Land Cruiser 78.
3. B Medical Systems provides the CF850 vaccine refrigerator.
4. Toyota Tsusho Group company CFAO SAS and Toyota Group company TOYOTA CUSTOMIZING & DEVELOPMENT Co., Ltd. conduct vehicle installation and conversion.
"We aim to deliver Safety and Security".
For this project, Toyota Tsusho, Toyota, and B-Medical Systems, have joined forces with the same goal in mind. We will continue to make efforts so that the obtainment of PQS for the refrigerated vehicle for vaccines will contribute to the Safety and Security of the region.
Source: Toyota Motor Corporation
Sectors: Automotive, Motorsports
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Galaxy Payroll Group Limited and People Intelligence Singapore Pte. Ltd. Announce Strategic Partnership
Jan 03, 2025 20:41 JST
Gruelling Challenge Awaits TGR In Saudi Arabia
Dec 27, 2024 15:20 JST
The General Incorporated Association Generative AI Japan Announces the Winners of the Japan Generative AI Award 2024
Dec 27, 2024 11:00 JST
MHI Included in "World Index" of Dow Jones Sustainability Index for Second Consecutive Year
Dec 27, 2024 09:36 JST
TOYOTA GAZOO Racing to Exhibit at Tokyo Auto Salon 2025
Dec 26, 2024 17:11 JST
JCB Launches Red Guahan Shopping Mall Shuttle Free Ride Promotion in Guam
Dec 26, 2024 12:00 JST
Mazda Production and Sales Results for November 2024
Dec 26, 2024 11:46 JST
MHI Conducts Nighttime and Long-Distance Highway Demonstration Testing of Unmanned Aerial Vehicle Currently Under Development
Dec 26, 2024 09:47 JST
Hitachi delivers a turnkey rail solution for Ho Chi Minh City's first urban railway Line 1 in Vietnam
Dec 24, 2024 13:19 JST
Nissan and Honda sign MOU to consider business integration
Dec 24, 2024 11:18 JST
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Year
Dec 24, 2024 11:00 JST
GAC Honda Begins Operation of New Energy Vehicle (NEV) Production Factory in Guangzhou, China
Dec 24, 2024 10:23 JST
Sarawak Premier Makes Inaugural Visit to Mitsubishi Power's Takasago Hydrogen Park
Dec 24, 2024 10:10 JST
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
Dec 23, 2024 17:22 JST
Nissan, Honda, and Mitsubishi Motors sign MOU on collaborative considerations
Dec 23, 2024 13:54 JST
Fujitsu drives chemical industry logistics DX with participation in joint logistics demonstration
Dec 23, 2024 13:30 JST
Mitsubishi Motors Cumulative Production Reaches One Million Units in Indonesia
Dec 20, 2024 17:35 JST
Contract Renewed on Operation and Maintenance (O&M) Services for APM System at Washington Dulles International Airport
Dec 20, 2024 17:24 JST
Toyota Launches Alphard and Vellfire PHEV Models in Japan
Dec 20, 2024 15:38 JST
6G Begins! Embarking on a New Journey of Global Interoperable Standards
Dec 19, 2024 16:50 JST
More Latest Release >>
Related Release
Gruelling Challenge Awaits TGR In Saudi Arabia
12/27/2024 3:20:00 PM JST
TOYOTA GAZOO Racing to Exhibit at Tokyo Auto Salon 2025
12/26/2024 5:11:00 PM JST
Toyota Launches Alphard and Vellfire PHEV Models in Japan
12/20/2024 3:38:00 PM JST
Toyota's Fuel Cell and Water Electrolysis System Production Plan Certified as a METI Support Program for Building GX Supply Chains
12/18/2024 1:51:00 PM JST
TGR Announces Partially Upgraded Supra (3.0-liter) and Special-edition Supra "A90 Final Edition"
11/29/2024 11:22:00 AM JST
TOYOTA GAZOO Racing FULLY PREPARED FOR DAKAR 2025
11/26/2024 5:55:00 PM JST
TOYOTA GAZOO Racing reinforces WRC line-up with youth and experience for 2025
11/25/2024 5:10:00 PM JST
Toyota Submits Progress Report on Recurrence Prevention Measures
11/25/2024 3:43:00 PM JST
Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
11/18/2024 9:25:00 AM JST
Toyota: HySE to participate in the Dakar 2025 "Mission 1000 ACT2" with the HySE-X2, to tackle further technical challenges
11/12/2024 8:04:00 PM JST
More Press release >>